Published in Br J Pharmacol on October 01, 1998
Mechanisms of the cutaneous vasodilator response to local external pressure application in rats: involvement of CGRP, neurokinins, prostaglandins and NO. Br J Pharmacol (2000) 1.03
Endothelin-1-induced ET(A) receptor-mediated nociception, hyperalgesia and oedema in the mouse hind-paw: modulation by simultaneous ET(B) receptor activation. Br J Pharmacol (2000) 0.98
Endothelin-1 and its role in the pathogenesis of infectious diseases. Life Sci (2014) 0.86
Endogenous cannabinoids induce fever through the activation of CB1 receptors. Br J Pharmacol (2009) 0.83
Central mediators involved in the febrile response: effects of antipyretic drugs. Temperature (Austin) (2015) 0.83
The endothelin system has a significant role in the pathogenesis and progression of Mycobacterium tuberculosis infection. Infect Immun (2014) 0.78
The antipyretic effect of dipyrone is unrelated to inhibition of PGE(2) synthesis in the hypothalamus. Br J Pharmacol (2011) 0.78
Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology (Oxford) (2005) 2.19
Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration "in vivo" by indirect mechanisms. Agents Actions (1990) 1.71
Effects of peptides and non-peptides on isolated arterial smooth muscles: role of endothelium. Eur J Pharmacol (1985) 1.64
Selective agonists for substance P and neurokinin receptors. Neuropeptides (1987) 1.51
Pharmacological receptors for substance P and neurokinins. Life Sci (1987) 1.50
Kawasaki disease and juvenile systemic lupus erythematosus. Lupus (2011) 1.44
Growth regulatory properties of endothelins. Peptides (1993) 1.35
The actions of kinin antagonists on B1 and B2 receptor systems. Eur J Pharmacol (1986) 1.31
Endothelins: circulating plasma levels and presence in other biologic fluids. Lab Invest (1993) 1.25
Different receptors are involved in the endothelium-mediated relaxation and the smooth muscle contraction of the rabbit pulmonary artery in response to substance P and related neurokinins. Eur J Pharmacol (1986) 1.24
Receptors for substance P. I. The pharmacological preparations. Eur J Pharmacol (1984) 1.24
Characterization of neurokinin receptors in various isolated organs by the use of selective agonists. Life Sci (1987) 1.14
Tissue-engineered composites of bone and cartilage for mandible condylar reconstruction. J Oral Maxillofac Surg (2001) 1.12
Receptors for substance P and related neurokinins. Pharmacology (1989) 1.11
The rat isolated portal vein: a preparation sensitive to neurokinins, particularly neurokinin B. Eur J Pharmacol (1987) 1.08
The modulatory role played by TNF-alpha and IL-1 beta in the inflammatory responses induced by carrageenan in the mouse model of pleurisy. Cytokine (2001) 1.07
Processing of proendothelin-1 by human furin convertase. FEBS Lett (1995) 1.07
In vivo B1 kinin-receptor upregulation. Evidence for involvement of protein kinases and nuclear factor kappaB pathways. Br J Pharmacol (1999) 1.03
Alveolar hemorrhage: distinct features of juvenile and adult onset systemic lupus erythematosus. Lupus (2012) 1.01
Nonadrenergic and noncholinergic arterial dilatation and venoconstriction are mediated by calcitonin gene-related peptide1 and neurokinin-1 receptors, respectively, in the mesenteric vasculature of the rat after perivascular nerve stimulation. J Pharmacol Exp Ther (1992) 1.01
A population-based study of drug resistance and transmission of tuberculosis in an urban community. Int J Tuberc Lung Dis (2005) 1.01
Upregulation of B1 receptor mediating des-Arg9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin. Br J Pharmacol (1996) 0.98
Endothelin-1-induced ET(A) receptor-mediated nociception, hyperalgesia and oedema in the mouse hind-paw: modulation by simultaneous ET(B) receptor activation. Br J Pharmacol (2000) 0.98
Presence of a phosphoramidon-sensitive endothelin-converting enzyme which converts big-endothelin-1, but not big-endothelin-3, in the rat vas deferens. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.96
Conversion of kinins and their antagonists into B1 receptor activators and blockers in isolated vessels. Eur J Pharmacol (1986) 0.94
Pharmacology of kinins in the arterial and venous mesenteric bed of normal and B2 knockout transgenic mice. Eur J Pharmacol (1997) 0.94
A Brazilian registry of juvenile dermatomyositis: onset features and classification of 189 cases. Clin Exp Rheumatol (2010) 0.93
Endothelin-1 inhibits PAF-induced paw oedema and pleurisy in the mouse. Br J Pharmacol (1992) 0.93
Analgesic activity of the lignans from Lychnophora ericoides. Phytochemistry (2000) 0.93
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test. Eur J Neurosci (2003) 0.92
DuP 753 is a specific antagonist for the angiotensin receptor. Hypertension (1991) 0.92
Noradrenaline supersensitivity of the mouse vas deferns after long-term treatment with morphine. J Pharm Pharmacol (1977) 0.92
Hydrolysis of P2-purinoceptor agonists by a purified ectonucleotidase from the bovine aorta, the ATP-diphosphohydrolase. Biochem Pharmacol (1996) 0.92
Effects of endothelin-1 on capsaicin-induced nociception in mice. Eur J Pharmacol (1998) 0.91
Modulation of kinin B1 but not B2 receptors-mediated rat paw edema by IL-1beta and TNFalpha. Peptides (1998) 0.90
Is methylnalorphinium the prototype of an ideal peripheral analgesic? Eur J Pharmacol (1984) 0.90
Endothelin-1 induces vasoconstriction and prostacyclin release via the activation of endothelin ETA receptors in the perfused rabbit kidney. Eur J Pharmacol (1993) 0.89
Heterozygous knock-Out of ET(B) receptors induces BQ-123-sensitive hypertension in the mouse. Hypertension (2000) 0.89
Complement and antibody primary immunodeficiency in juvenile systemic lupus erythematosus patients. Lupus (2011) 0.89
Undeca- and octa-peptide antagonists for substance P, a study on the guinea pig trachea. Eur J Pharmacol (1984) 0.88
Chronic polyarthritis as the first manifestation of juvenile systemic lupus erythematosus patients. Lupus (2011) 0.88
Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.88
Oligoclonal gamma-globulin of cerebrospinal fluid in neurobrucellosis. Acta Neurol Scand (1980) 0.88
In-vivo blockage of neutrophil migration by LPS is mimicked by a factor released from LPS-stimulated macrophages. Br J Exp Pathol (1989) 0.88
Interleukin-8 induces fever by a prostaglandin-independent mechanism. Am J Physiol (1994) 0.88
Effect of crude extracts from Leonotis nepetaefolia (Labiatae) on rat and guinea-pig smooth muscle and rat cardiac muscle. J Pharm Pharmacol (1991) 0.88
The use of confocal microscopy in the investigation of cell structure and function in the heart, vascular endothelium and smooth muscle cells. Mol Cell Biochem (1997) 0.88
Activities and antagonism of bombesin on urinary smooth muscles. Eur J Pharmacol (1985) 0.87
ET(B) receptor and nitric oxide synthase blockade induce BQ-123-sensitive pressor effects in the rabbit. Hypertension (1997) 0.87
Endotoxin-induced fever is modulated by endogenous glucocorticoids in rats. Am J Physiol (1992) 0.87
Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice. Eur J Pharmacol (1996) 0.87
Antispasmodic effects of an alkaloid extracted from Phyllanthus sellowianus: a comparative study with papaverine. Braz J Med Biol Res (1984) 0.87
Subclinical impairment of ovarian reserve in juvenile systemic lupus erythematosus after cyclophosphamide therapy. Clin Exp Rheumatol (2012) 0.87
Pharmacology of endothelins: vascular preparations for studying ETA and ETB receptors. Mol Cell Biochem (1996) 0.87
Neurofibrillary changes in the cerebral cortex of a patient with subacute sclerosing panencephalitis (SSPE). Acta Neuropathol (1979) 0.86
Dual effects of endothelins -1, -2 and -3 on guinea pig field-stimulated ileum: possible mediation by two receptors coupled to pertussis toxin-insensitive mechanisms. J Pharmacol Exp Ther (1992) 0.86
Bronchodilator activity of Mikania glomerata Sprengel on human bronchi and guinea-pig trachea. J Pharm Pharmacol (2002) 0.86
Novel inhibitors of nucleoside triphosphate diphosphohydrolases: chemical synthesis and biochemical and pharmacological characterizations. J Med Chem (2000) 0.86
A comparative study of the antipyretic effects of indomethacin and dipyrone in rats. Inflamm Res (2002) 0.86
ETA receptor antagonists inhibit allergic inflammation in the mouse. J Cardiovasc Pharmacol (1995) 0.86
Different pressor and bronchoconstrictor properties of human big-endothelin-1, 2 (1-38) and 3 in ketamine/xylazine-anaesthetized guinea-pigs. Br J Pharmacol (1995) 0.85
Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists. Eur J Pharmacol (1985) 0.85
Endothelin-1 (1-31): from chymase-dependent synthesis to cardiovascular pathologies. Vascul Pharmacol (2008) 0.85
Supersensitivity to noradrenaline in vas deferens from morphine-dependent mice is confirmed. Eur J Pharmacol (1983) 0.85
Endothelins potentiate formalin-induced nociception and paw edema in mice. Can J Physiol Pharmacol (1997) 0.85
Effects of endothelin-1 on inflammatory incapacitation of the rat knee joint. J Cardiovasc Pharmacol (1998) 0.85
Macrophages stimulated with lipopolysaccharide release a selective neutrophil chemotactic factor: an in vivo demonstration. Braz J Med Biol Res (1986) 0.85
Angiotensin II AT1 receptor internalization, translocation and de novo synthesis modulate cytosolic and nuclear calcium in human vascular smooth muscle cells. Can J Physiol Pharmacol (2003) 0.84
Role of endothelins on lymphocyte accumulation in allergic pleurisy. J Leukoc Biol (2000) 0.84
Bradykinin antagonism: differentiation between peptide antagonists and antiinflammatory agents. Eur J Pharmacol (1988) 0.84
Peripheral kinin B(1) and B(2) receptor-operated mechanisms are implicated in neuropathic nociception induced by spinal nerve ligation in rats. Neuropharmacology (2007) 0.84
Vasoactive peptides and their receptors. Blood Vessels (1990) 0.84
ET(B) receptor blockade potentiates the pressor response to big endothelin-1 but not big endothelin-2 in the anesthetized rabbit. Hypertension (2000) 0.84
Clinical and CSF cyto-proteic findings in 23 patients with CSF eosinophilia. Acta Neurol Scand (1986) 0.84
Changes in paw oedema triggered via bradykinin B(1) and B(2) receptors in streptozotocin-diabetic rats. Eur J Pharmacol (2001) 0.83
Pharmacology of two novel mixed ETA/ETB receptor antagonists, BQ-928 and 238, in the carotid and pulmonary arteries and the perfused kidney of the rabbit. Br J Pharmacol (1997) 0.83
Pharmacological properties of endothelins and big endothelins in ketamine/xylazine or urethane anesthetized rats. Am J Hypertens (1995) 0.83
Endogenous cannabinoids induce fever through the activation of CB1 receptors. Br J Pharmacol (2009) 0.83
Molecular and pharmacological evidence for modulation of kinin B(1) receptor expression by endogenous glucocorticoids hormones in rats. Br J Pharmacol (2001) 0.83
Effects of kinins on isolated blood vessels. Role of endothelium. Can J Physiol Pharmacol (1982) 0.83
Antagonists of substance P. Eur J Pharmacol (1982) 0.83
Validation of the Portuguese Simple Measure of Impact of Lupus Erythematosus in Youngsters (SMILEY) in Brazil. Lupus (2012) 0.83
Common variable immunodeficiency associated with hepatosplenic T-cell lymphoma mimicking juvenile systemic lupus erythematosus. Clin Dev Immunol (2011) 0.83
Anti-C1q antibodies in juvenile-onset systemic lupus erythematosus. Ann N Y Acad Sci (2009) 0.82
Contribution of endogenous endothelin-1 and endothelin-A-receptors to the hypertensive state of endothelin-B heterozygous (+/-) knockout mice. J Cardiovasc Pharmacol (2000) 0.82
Inhibition of convertase-related processing of proendothelin-1. J Cardiovasc Pharmacol (1995) 0.82
N-acetyl transferase 2 and cytochrome P450 2E1 genes and isoniazid-induced hepatotoxicity in Brazilian patients. Int J Tuberc Lung Dis (2013) 0.82
Presence of functional endothelin-1 receptors in nuclear membranes of human aortic vascular smooth muscle cells. J Cardiovasc Pharmacol (2000) 0.82